Spradlin et al. recently indicated that Nimbolide, a terpenoid natural product derived from the Neem tree, impairs breast cancer pathogenicity by disrupting RNF114 interactions, thus inhibiting p21 ubiquitination and degradation [157]. Here, RNF114 is linked to breast carcinoma.